可以在产品的外部标签上找到：
产品编号
1237624
CAS 号
73590-58-6
中文名称
6-甲氧基-2-((((4-甲氧基-3,5-二甲基吡啶-2-基)甲基)亚磺酰基)-1H-苯并[d]咪唑（埃索美拉唑杂质）
MDL 号
MFCD00083192
分子量
345.42
存储条件
2-8°C, stored under nitrogen
网页展示纯度为入库指导纯度值，各批次间存在一定差异，实际纯度以收货为准
熔点
158-159 °C
沸点
600.0±60.0 °C at 760 mmHg
闪点
旋光
描述
TPSA
77.1
LogP
2.89974
H_Acceptors
5
H_Donors
1
Rotatable_Bonds
5
[1]. Anne-Charlotte Dubbelman, et al. Systematic evaluation of commercially available ultra-high performance liquid chromatography columns for drug metabolite profiling: optimization of chromatographic peak capacity. J Chromatogr A. 2014 Dec 29:1374:122-133.
[2]. B W Sykes, et al. Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse. J Vet Pharmacol Ther. 2015 Apr;38(2):130-6.
[3]. Dany Spaggiari, et al. Comparison of liquid chromatography and supercritical fluid chromatography coupled to compact single quadrupole mass spectrometer for targeted in vitro metabolism assay. J Chromatogr A. 2014 Dec 5:1371:244-56.
[4]. Jong Min Choi, et al. HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics. Arch Pharm Res. 2015;38(5):691-704.
[5]. Julia Dinger, et al. Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail. Anal Bioanal Chem. 2014 Jul;406(18):4453-64.
警示图
警示词
Warning
危险申明
H302-H317-H402-H411
警告申明
P261-P264-P270-P272-P273-P280-P302+P352-P363-P391-P501
GHS 编码
GHS07,GHS09
危险类别
9
UN 编码
3077
包装等级
Ⅲ
现货供应
专业护航
售后无忧
品质保障
无需凑单
沪ICP备17019645号
400-821-0725
